FSD Pharma Inc.
HUGE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $17 | $35 | $18 |
| Short-Term Investments | $1 | $0 | $0 | $0 |
| Receivables | $7 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $10 | $9 |
| Total Curr. Assets | $11 | $18 | $46 | $27 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $5 | $12 | $16 | $13 |
| Long-Term Investments | $0 | $1 | $1 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $7 | -$0 | -$0 |
| Total NC Assets | $6 | $21 | $17 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17 | $38 | $63 | $42 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $5 | $0 |
| Other Curr. Liab. | $1 | $5 | $5 | $3 |
| Total Curr. Liab. | $5 | $8 | $9 | $6 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $8 | $9 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $137 | $143 | $152 | $103 |
| Retained Earnings | -$158 | -$144 | -$126 | -$91 |
| AOCI | $0 | $1 | $0 | $0 |
| Other Equity | $33 | $31 | $28 | $24 |
| Total Equity | $13 | $31 | $54 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $17 | $38 | $63 | $42 |
| Net Debt | -$2 | -$16 | -$35 | -$17 |